You searched for ESKD

Your search for ESKD returned 7 results

Sort Results:

Relevant Recent

Did you mean: esrd

News

Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum

September 7, 2021

In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.

News

Even Low Levels of Lead in Drinking Water May Harm ESKD Patients

July 20, 2021

Hemoglobin levels lower, erythropoietin stimulating agent use higher, even for water lead levels below EPA threshold for regulatory action

News

Acute Kidney Injury in Severe COVID-19 Cases Predicts Higher Death, Cardiovascular Risks

July 6, 2021

A study found no significant increased risks for death or major adverse cardiac events among infected patients with established chronic kidney disease or end-stage kidney disease.

News

Psoriasis Treatment May Decrease Infection, Death Risk in End-Stage Kidney Disease

May 14, 2021

Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.

News

Dapagliflozin Reduces Risk for Kidney Events in IgA Nephropathy

May 6, 2021

In patients with IgA nephropathy, dapagliflozin significantly reduced the risk of CKD progression when added to ACEi/ARB therapy.

News

DOACs Appear Safer Than Warfarin Across Chronic Kidney Disease Stages

April 29, 2021

Although more research is needed, data suggest that the cardioprotective effect of direct oral anticoagulants may extend to patients with advanced CKD.

News

Vadadustat Noninferior to Darbepoetin in CKD

September 10, 2020

Despite favorable efficacy data, the HIF-PHI failed to demonstrate noninferiority to the ESA in patients with CKD with respect to the primary MACE safety endpoint.

Your search for ESKD returned 7 results

Active Filters

Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum

Even Low Levels of Lead in Drinking Water May Harm ESKD Patients

Acute Kidney Injury in Severe COVID-19 Cases Predicts Higher Death, Cardiovascular Risks

Psoriasis Treatment May Decrease Infection, Death Risk in End-Stage Kidney Disease

Dapagliflozin Reduces Risk for Kidney Events in IgA Nephropathy

DOACs Appear Safer Than Warfarin Across Chronic Kidney Disease Stages

Vadadustat Noninferior to Darbepoetin in CKD